// App-Quantinova.ai

PB1671 : VALIDATION OF THE MYRADS REPORTING CRITERIA USING DATA FROM A PROSPECTIVE IMAGING STUDY IN PLASMA CELL DYSCRASIAS (LOOMIS).

Researchers

Presenter

  • Guido Nador

Principal Investigators

  • Sarah Gooding

  • Chris Rodgers

  • Claudio Pereira

  • Neel Patel

  • M Kassim Javaid

  • Hiwot Getu

  • Raj Soundarajan

  • Rebecca Mills

  • Jaimal Kothari

  • Sherin Varghese

  • Richard Brouwer

  • Delia Peppercorn

  • Aarti Shah

  • Karthik Ramasamy

Medical Centers

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • Hampshire Hospitals Foundation Trust, Winchester, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • University of Cambridge, Cambridge, United Kingdom

  • University of Oxford, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Endocrine/metabolic Diseases (ME)

Disease

  • Multiple Myeloma

  • Monoclonal gammopathy

Biomarkers

  • Apparent diffusion coefficient

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • NCT03951220

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved